Victor Palit

Hypoxia-inducible factor-1α and -2α are expressed in most rectal cancers but only hypoxia-inducible factor-1α is associated with prognosis

EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016

Targeting hypoxia in cancer therapy

Lung Cancer

Meta‐analysis: does lidocaine gel before flexible cystoscopy provide pain relief?

The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence

Accelerated Radiotherapy, Carbogen, and Nicotinamide (ARCON) in the Treatment of Advanced Bladder Cancer: Mature Results of a Phase II Nonrandomized Study

EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013

Apaziquone as an intravesical therapeutic agent for urothelial non-muscle-invasive bladder cancer

Pharmacological targeting of the HIF hydroxylases – A new field in medicine development

The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm

The Hypoxic Tumour Microenvironment, Patient Selection and Hypoxia-modifying Treatments

Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy

Response of Multiple Recurrent TaT1 Bladder Cancer to Intravesical Apaziquone (EO9): Comparative Analysis of Tumor Recurrence Rates

Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics

Phase II Marker Lesion Study With Intravesical Instillation of Apaziquone for Superficial Bladder Cancer: Toxicity and Marker Response

Role of Hypoxia Inducible Factor-1α (HIF-1α) in Innate Defense against Uropathogenic Escherichia coli Infection

Open Surgical Repair of Abdominal Aortic Aneurysm Coexisting with Horseshoe Kidney

Oxygen Sensing, Hypoxia-Inducible Factors, and Disease Pathophysiology

Biomedical Importance of Indoles

Phase I/II clinical evaluation of intravesical EOquin (EO9) against superficial bladder cancer

Is Using Lignocaine Gel prior to Flexible Cystoscopy Justified?

Laparoscopic Heminephrectomy of a Horseshoe Kidney

Expression of HIF-1α and Glut-1 in human bladder cancer

Phase I/II Pilot Study of Intravesical Apaziquone (EO9) for Superficial Bladder Cancer